The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrakm8 Hldgs Regulatory News (TRAK)

Share Price Information for Trakm8 Hldgs (TRAK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
TRAK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Apr 2022 07:00

RNS Number : 2611J
Trakm8 Holdings PLC
26 April 2022
 

 

26 April 2022

Trakm8 Holdings plc

("Trakm8", the "Group" or the "Company")

Trading Update

Trakm8 Holdings plc (AIM: TRAK), the global telematics and data insight provider, today announces a trading update for its financial year ended 31 March 2022.

Revenues for the full year ended 31 March 2022 were £18.2m, which is 14% more than the prior financial year. Revenues from Fleet customers amounted to £11.3m, 19% more than last year. In a year that started in lockdown and when driving tests and availability of second hand cars were negatively impacted by Covid-19, revenues from Insurance customers amounted to £6.9m, 7% more than last year as a result of a strong fourth quarter for new policy sales and new customer launches.

The Group expects to achieve an adjusted profit before tax for the financial year in line with previous guidance of circa £7k (FY-2021: Adjusted loss of £0.3m) and a profit after tax of £0.2m (FY-2021: Loss after tax of £1.2m)

Cash generation from operating activities at £3.6m, has been as expected and at 31 March 2022 the Group net debt was £5.4m (£7.0m after IFRS 16 changes), which is £0.5m higher than as at 31 March 2021 and a £0.8m reduction since 30 Sept 2021. At the year end, the Group had £1.0m of cash on hand and a further £0.5m of available funds under an overdraft facility. During the financial year, the Group reduced the long term liability to HMRC by £0.9m to £0.9m in line with an agreement reached last year.

During the year, connections increased by 4% to 264,000 (FY-2021: 254,000). Fleet connections increased by 1% to 71,000 (FY-2021: 70,000), Insurance & Automotive connections increased by 5% to 193,000 (FY-2021: 184,000). The resulting recurring revenues in the year increased by 5% to £9.8m, representing 54% of Group revenues.

Software revenues increased by 149% to £1.3m, representing 7% of Group revenues.

The Group has had to deal with a number of significant supply chain challenges but, with the benefit of our fully integrated business model, has successfully avoided any meaningful interruptions to customer deliveries during the period. There has however been an impact on the Group's costs and we estimate this amounted to £0.2m during the financial year.

We were pleased to advise during the year that several major contract awards, extensions and renewals were secured.

Further new products and solutions were introduced to the market that will continue to improve the costs and functionality of the solutions we sell.

 

Outlook

A major challenge for Trakm8 post Covid-19 and now the war in Ukraine will be the security of component supply where it faces challenges weekly of varying significance. However, the Group continues to take steps to minimise these risks.

There are a number of Fleet deployment contract renewals during 2022 which are important to the outcome for the year and the timing of which will lead to Group revenue being second half weighted. Growth in Insurance policy sales will be dependent on the level of activity from the new customers which have been announced, alongside a return to more normal sales at existing customers.

Like many businesses, Trakm8 is currently experiencing significant salary and component inflationary pressures. Whilst it is unlikely that the Group will be able to mitigate all of these cost increases, it is taking what steps it can to achieve this.

The Board looks forward to providing an update on Trakm8's trading performance in the current financial year at the time of publication of the Group's results for the year ended 31 March 2022. 

 

- Ends -

For further information:

Trakm8 Holdings plc

John Watkins, Executive Chairman

Tel: +44 (0) 167 543 4200

Jon Edwards, CFO

www.trakm8.com

 

Arden Partners plc (Nominated Adviser & Broker)

Tel: +44 (0) 20 7614 5900

Paul Shackleton, Corporate Finance

Simon Johnson, Corporate Broking

www.arden-partners.com

 

 

 

 

About Trakm8

 

Trakm8 is a UK based technology leader in fleet management, insurance telematics, connected car, and optimisation. Through IP owned technology, the Group uses AI data analytics collected from its installed base of telematics units to fine tune the algorithms that are used to produce its' solutions; these monitor driver behaviour, identify crash events and monitor vehicle health to provide actionable insights to continuously improve the security and operational efficiency of both company fleets and private drivers.

 

The Group's product portfolio includes the latest data analytics and reporting portal (Trakm8 Insight), integrated telematics/cameras/optimisation, self-installed telematics units and one of the widest ranges of installed telematics devices. Trakm8 has over 264,000 connections.

 

Headquartered in Coleshill near Birmingham alongside its manufacturing facility, the Group supplies to the Fleet, Optimisation, Insurance and Automotive sectors to many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Iceland Foods, GSF, Direct Line Group, Ticker and Ingenie.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005. Trakm8 is also recognised with the LSE Green Economy Mark.

 

www.trakm8.com / @Trakm8

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSESFIIEESELL
Date   Source Headline
3rd Apr 20247:00 amRNSTrading Update, Contract Extension & CLNs Issue
22nd Mar 20247:00 amRNSTrading update
24th Nov 20237:00 amRNSHalf-year Report
15th Nov 20239:37 amRNSDirectorate Change
7th Nov 20239:46 amRNSHolding(s) in Company
21st Sep 202311:13 amRNSResult of Annual General Meeting (AGM)
21st Sep 20237:00 amRNSAGM Statement & Trading Update
25th Aug 20237:00 amRNSNotice of AGM and Capital Markets Day
7th Jul 202311:18 amRNSAward of options
4th Jul 20237:00 amRNSFinal Results
25th Apr 20237:00 amRNSYear End Trading Update
20th Apr 20237:00 amRNSContract Award
30th Mar 20237:00 amRNSIceland Foods Awards Contract Extension
29th Mar 20237:00 amRNSSainsbury’s Awards Optimisation Contract Extension
28th Mar 20237:00 amRNSContract Award
22nd Feb 20237:00 amRNSCapital Markets Day
15th Dec 20228:05 amRNSAward of Options
8th Dec 20227:00 amRNSHalf Year Results
28th Nov 202211:58 amRNSDirector Dealing
22nd Sep 202210:46 amRNSResult of Annual General Meeting (AGM)
22nd Sep 20227:00 amRNSAGM Statement & Trading Update
14th Sep 20228:00 amRNSTrading and Strategy Update and Issue of CLN
18th Aug 20227:00 amRNSNotice of AGM
22nd Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
6th Jul 20227:00 amRNSContract Award
29th Jun 20227:00 amRNSFinal Results
27th Apr 20222:00 pmRNSChange of Nominated Adviser and Broker
26th Apr 20227:00 amRNSTrading Update
29th Mar 20227:00 amRNSContract Extension
22nd Mar 20227:00 amRNSContract Award
18th Mar 20227:00 amRNSContract Extension
2nd Dec 20217:00 amRNSContract Award
19th Nov 20213:57 pmRNSAward of Options
16th Nov 20217:00 amRNSHalf Year Results and Director Change
1st Oct 20217:00 amRNSAppointment of Director
27th Sep 20217:00 amRNSAward of Green Economy Mark
23rd Sep 202111:00 amRNSResult of Annual General Meeting (AGM)
23rd Sep 20217:00 amRNSAGM Statement & Trading Update
19th Aug 20212:33 pmRNSNotice of Annual General Meeting
13th Jul 20217:00 amRNSAward of options
12th Jul 20217:00 amRNSDirectorate Change
29th Jun 20217:00 amRNSFinal Results
22nd Jun 20217:00 amRNSNotice of Results
28th Apr 20217:00 amRNSYear End Trading Update
12th Mar 20217:00 amRNSDirector Dealings
25th Feb 20217:00 amRNSContract Award and Trading Update
30th Nov 20207:00 amRNSIssue of Options
23rd Nov 20207:00 amRNSHalf-Year Results
17th Sep 202010:00 amRNSResult of AGM
17th Sep 20207:00 amRNSChairman's Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.